Avidia AVBC Q1 2026 Beat Revenue NA EPS Exceeds by Significant Tyra Biosciences TYRA Q1 2026 Miss What Went Wrong Antalpha ANTA Q1 2026 Beat Revenue NA EPS Exceeds by Significant Nasdaq Leads Market Losses as Rising Oil Prices and Borrowing Costs Weigh on Sentiment